Back to today’s briefing

Story perspectives

Rapamycin Shows Promise for Lifespan Extension, Human Trials Begin

6/23/2025

37 4

Summary

Story summary

A groundbreaking study suggests that rapamycin could extend lifespan much like dietary restrictions, while metformin appears ineffective. Researchers examined 167 studies across different species, highlighting rapamycin's potential in anti-aging treatments. Yet, caution is advised due to possible side effects and inconsistent results. Excitingly, human trials are underway, showing early health benefits from low doses of rapamycin.

1 of 1

Story summary

A groundbreaking study suggests that rapamycin could extend lifespan much like dietary restrictions, while metformin appears ineffective. Researchers examined 167 studies across different species, highlighting rapamycin's potential in anti-aging treatments. Yet, caution is advised due to possible side effects and inconsistent results. Excitingly, human trials are underway, showing early health benefits from low doses of rapamycin.